These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients.
    Author: Harrison A, Borg B, Thompson B, Hew M, Dabscheck E.
    Journal: Intern Med J; 2017 Nov; 47(11):1310-1313. PubMed ID: 29105270.
    Abstract:
    The Australian National Chronic Obstructive Pulmonary Disease (COPD) guidelines recommend that inhaled corticosteroids (ICS) be reserved for patients with a post-bronchodilator forced expiratory volume in 1 s (FEV1 ) less than 50% predicted and those who experience ≥2 exacerbations in 12 months. In total, 707 COPD patients were identified from the lung function test database at our tertiary hospital; 52.4% of patients with a post-bronchodilator FEV1 ≥50% were prescribed an ICS. Significant discordance exists between guideline recommendations and inhaler prescription.
    [Abstract] [Full Text] [Related] [New Search]